Ipca Laboratories Limited Ipca Laboratories Limited

Ipca Laboratories Limited

IPCALAB

Classificação em ações #3416
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Preço da ação
$20.02
Última sincronização: 2026-10-19
Valor de mercado
$5.08B
Variação (1 dia)
-1.65%
Variação (1 ano)
38.46%
País
IN
Negociar Ipca Laboratories Limited (IPCALAB)

Categoria

Healthcare
Histórico de desdobramentos de ações de Ipca Laboratories Limited (IPCALAB)
As ações Ipca Laboratories Limited (símbolo: IPCALAB) passaram por um total de 3 desdobramentos.
O desdobramento mais recente ocorreu em Jan 10, 2022.
Uma ação IPCALAB comprada antes de Jan 28, 2005 equivaleria hoje a 20 ações IPCALAB.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
2022-01-10 2:1 x2 x20
2010-03-22 5:1 x5 x10
2005-01-28 2:1 x2 x2
Desdobramentos de ações de empresas semelhantes ou concorrentes